Filter
839
Filtered Results: 839
Text search:
vials
Featured
Recommendations
126
New Publications
238
Language
Document type
No document type
396
Guidelines
212
Studies & Reports
92
Manuals
57
Fact sheets
30
Strategic & Response Plan
21
Training Material
12
Infographics
10
Situation Updates
5
Resource Platforms
2
Online Courses
2
Countries / Regions
India
86
Global
24
Kenya
23
South Africa
23
Ethiopia
22
Argentina
17
Philippines
16
Nepal
15
Nigeria
15
Uganda
15
Africa
14
Latin America and the Carribbean
14
Zambia
13
Liberia
13
Sierra Leone
12
Tanzania
12
Rwanda
9
Indonesia
9
Malawi
8
Venezuela
8
Paraguay
8
Brazil
8
Ghana
7
Zimbabwe
7
Congo, Democratic Republic of
7
West and Central Africa
6
Bangladesh
6
Syria
5
Burkina Faso
5
Haiti
5
South–East Asia Region
5
Western and Central Europe
5
Ecuador
5
Myanmar / Burma
5
Ukraine
4
Senegal
4
Peru
4
Cambodia
4
Bolivia
4
Namibia
4
Eswatini/ Swaziland
4
Pakistan
4
Cameroon
3
Guinea
3
Middle East and North Africa
3
Spain
3
East and Southern Africa
3
Russia
3
Greece
3
Mali
3
Angola
3
Botswana
3
Afghanistan
2
Mozambique
2
Asia
2
Guinea-Bissau
2
North America
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Sudan
2
Yemen
2
Central African Republic
2
South Sudan
2
Somalia
2
Madagascar
2
Thailand
1
El Salvador
1
Lesotho
1
China
1
Chile
1
Iran
1
Albania
1
Fiji
1
Morocco
1
USA
1
Jordan
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
France
1
Tunisia
1
Portugal
1
Israel
1
Eastern Europe
1
Georgia
1
Libya
1
Bhutan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
365
Clinical Guidelines
123
Women & Child Health
46
Public Health
44
Key Resources
38
Capacity Building
21
Pharmacy & Technologies
17
Toolboxes
COVID-19
116
Pharmacy
85
Ebola
36
NTDs
33
Rapid Response
31
TB
31
Caregiver
31
AMR
28
HIV
23
NCDs
20
Polio
16
Planetary Health
14
Conflict
11
Refugee
7
Cholera
7
Zika
7
Mental Health
6
Natural Hazards
6
Specific Hazards
3
Disability
3
Global Health Education
3
Health Financing Toolbox
2
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Infection prevention and control (IPC) in a CTC/ CTU IPC are all practical measures taken in the healthcare facility to prevent harm caused by infections to patients, health workers and communities.
The main goal of IPC in the cholera response is to
• To reduce transmission of health care-as...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
A erradicação da varíola humana (mpox em inglês) foi certificada em 1980. A varíola símia (mpox em inglês) é endêmica nos países da África Central e Ocidental desde a sua primeira detecção, em 1958. Trata-se de uma zoonose cujos casos geralmente ocorrem perto de florestas tropicais, ond...
El 23 de julio del 2022, el Director General de la OMS declaró el brote de viruela símica una emergencia de salud pública de importancia internacional. A raíz de esa declaración, se puso en marcha un dispositivo de respuesta coordinada con el objeto de interrumpir la transmisión y proteger a l...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
Operational Guideline
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Guidance for health workers
6th edition
Information and Approaches for developing Country Settings
